The Biden administration’s push to introduce widespread vaccine boosters faces a test as a Food and Drug Administration advisory panel meets to weigh evidence on the extra shots, a topic that has divided federal health officials.
Product shortages also appear to have damped sales on items such as autos, restraining the economic recovery. Economists think sales could recover quickly once the Covid-19 surge eases.
The White House, FDA, and CDC are evidently not on the same page on COVID-19 booster shots
As early as Sept. 20, vaccinated Americans could start to get booster doses of COVID-19 vaccine. Who will be eligible at first is still being decided.
NPR's Rachel Martin talks with NIH director Francis Collins about President Biden's new plans to get the latest coronavirus surge under control and increase vaccinations across the country.
The U.S. coronavirus infection rate is more than 10 times the rate needed to end the pandemic, Dr. Anthony Fauci says.
A coalition of over 1,500 environmental groups spanning 130 countries is calling for the upcoming United Nations climate summit to be postponed amid spiking COVID-19 cases.The Climate Action Network argued on Tuesday that ...
Florida accounts for nearly a quarter of new U.S. COVID-19 deaths
Lawmakers are pushing for billions in federal funding to boost global COVID-19 vaccine manufacturing in Democrats' coming $3.5 trillion package, arguing that the Biden administration needs to do more to fight the pandemic worldwide and prevent...
A judge last week ruled that DeSantis exceeded his authority by ordering school boards not to impose mask requirements on students to combat the spread of the coronavirus.